{"clinical_study": {"@rank": "170", "required_header": {"download_date": "ClinicalTrials.gov processed this data on April 03, 2020", "link_text": "Link to the current ClinicalTrials.gov record.", "url": "https://clinicaltrials.gov/show/NCT04328129"}, "id_info": {"org_study_id": "2020-009", "nct_id": "NCT04328129"}, "brief_title": "Household Transmission Investigation Study for COVID-19 in French Guiana", "acronym": "EPI-COVID-19", "official_title": "Household Transmission Investigation Study for Coronavirus Disease 2019 (COVID-19) in French Guiana", "sponsors": {"lead_sponsor": {"agency": "Institut Pasteur", "agency_class": "Industry"}, "collaborator": [{"agency": "Institut Pasteur de la Guyane", "agency_class": "Other"}, {"agency": "Centre Hospitalier Andr\u00e9e Rosemon de Cayenne", "agency_class": "Other"}]}, "source": "Institut Pasteur", "oversight_info": {"has_dmc": "No", "is_fda_regulated_drug": "No", "is_fda_regulated_device": "No"}, "brief_summary": {"textblock": "This study is a interventional study that present minimal risks and constraints to evaluate\n      the presence of novel coronavirus (SARS-CoV-2) or antibodies among individuals living in\n      households where there is a confirmed coronavirus case in order to provide useful information\n      on the proportion of symptomatic forms and the extent of the virus transmission in a\n      territory such as French Guiana."}, "detailed_description": {"textblock": "This study is a interventional study that present minimal risks and constraints to evaluate\n      the presence of novel coronavirus (SARS-CoV-2) or antibodies among individuals living in\n      households where there is a confirmed coronavirus case in order to provide useful information\n      on the proportion of symptomatic forms and the extent of the virus transmission in a\n      territory such as French Guiana.\n\n      Subjects will be assessed (questionnaires and sampling) in their homes. Subjects will be\n      asked to attend study visits at days 0, 7, 14 and 28.\n\n      The primary objective of the study is to evaluate the rate of intra-household secondary\n      transmission of the virus."}, "overall_status": "Recruiting", "start_date": {"@type": "Actual", "#text": "March 23, 2020"}, "completion_date": {"@type": "Anticipated", "#text": "March 23, 2022"}, "primary_completion_date": {"@type": "Anticipated", "#text": "March 23, 2022"}, "phase": "N/A", "study_type": "Interventional", "has_expanded_access": "No", "study_design_info": {"allocation": "Non-Randomized", "intervention_model": "Parallel Assignment", "primary_purpose": "Screening", "masking": "None (Open Label)"}, "primary_outcome": {"measure": "Evaluation of the extent of the virus transmission within households", "time_frame": "2 years", "description": "The extent of the virus transmission within households will be assessed by evaluating the rate of intra-household secondary transmission of the virus"}, "secondary_outcome": [{"measure": "Characterization of the secondary cases", "time_frame": "2 years", "description": "The characterization of the secondary cases will be assessed by evaluating the proportion of asymptomatic forms within the household"}, {"measure": "Characterization of the secondary cases", "time_frame": "2 years", "description": "The characterization of the secondary cases will be assessed by characterizing the risk factors for coronavirus infection."}], "number_of_arms": "2", "enrollment": {"@type": "Anticipated", "#text": "450"}, "condition": ["Coronavirus Infections", "Severe Acute Respiratory Syndrome", "SARS-CoV Infection"], "arm_group": [{"arm_group_label": "Primary case", "arm_group_type": "Experimental", "description": "Subject with laboratory-confirmed coronavirus SARS-CoV-2 infection by polymerase chain reaction (PCR)"}, {"arm_group_label": "Family contact", "arm_group_type": "Experimental", "description": "Subject who lived in the household of the primary case while the primary case was symptomatic"}], "intervention": {"intervention_type": "Procedure", "intervention_name": "Human biological samples", "description": "Blood sample\nNasopharyngeal swab.", "arm_group_label": ["Family contact", "Primary case"]}, "eligibility": {"criteria": {"textblock": "Inclusion Criteria:\n\n          -  Primary case: laboratory-confirmed coronavirus SARS-CoV-2 infection by polymerase\n             chain reaction (PCR), or Family contact: person who lived in the same household as the\n             primary case of COVID-19 when the primary case was symptomatic. A household is defined\n             as a group of people (2 or more) living in the same accommodation (excluding\n             residential institutions such as boarding schools, dormitories, hostels, prisons,\n             other communities hosting grouped people)\n\n          -  Affiliated or beneficiary of a social security system\n\n          -  Informed consent prior to initiation of any study procedures from subject (or legally\n             authorized representative)\n\n          -  State of health compatible with a blood sample as defined in the protocol.\n\n        Exclusion Criteria:\n\n          -  Pregnant woman or breast feeding\n\n          -  Inability to consent\n\n          -  Person under guardianship or curatorship\n\n          -  Known pathology or a health problem contraindicated with the collect of blood sample."}, "gender": "All", "minimum_age": "N/A", "maximum_age": "N/A", "healthy_volunteers": "Accepts Healthy Volunteers"}, "overall_official": {"last_name": "Claude Flamand, PhD", "role": "Principal Investigator", "affiliation": "Institut Pasteur de la Guyane, Head of Epidemiology Unit"}, "overall_contact": {"last_name": "Claude Flamand, Phd", "phone": "+33 5 94 29 26 15", "email": "cflamand@pasteur-cayenne.fr"}, "overall_contact_backup": {"last_name": "Dominique Rousset, MD", "phone": "+33 5 94 29 26 09", "email": "drousset@pasteur-cayenne.fr"}, "location": [{"facility": {"name": "Centre Hospitalier Andr\u00e9e Rosemon", "address": {"city": "Cayenne", "country": "French Guiana"}}, "status": "Enrolling by invitation"}, {"facility": {"name": "Institut Pasteur de la Guyane", "address": {"city": "Cayenne", "country": "French Guiana"}}, "status": "Recruiting", "contact": {"last_name": "Claude Flamand, PhD", "phone": "+33 5 94 29 26 15", "email": "cflamand@pasteur-cayenne.fr"}, "contact_backup": {"last_name": "Dominique Rousset, MD", "phone": "+33 5 94 29 26 09", "email": "drousset@pasteur-cayenne.fr"}}], "location_countries": {"country": "French Guiana"}, "verification_date": "March 2020", "study_first_submitted": "March 23, 2020", "study_first_submitted_qc": "March 27, 2020", "study_first_posted": {"@type": "Actual", "#text": "March 31, 2020"}, "last_update_submitted": "March 27, 2020", "last_update_submitted_qc": "March 27, 2020", "last_update_posted": {"@type": "Actual", "#text": "March 31, 2020"}, "responsible_party": {"responsible_party_type": "Sponsor"}, "keyword": ["SARS-CoV-2", "COVID-19", "Serology", "French Guiana"], "condition_browse": {"mesh_term": ["Infection", "Communicable Diseases", "Coronavirus Infections", "Severe Acute Respiratory Syndrome"]}, "patient_data": {"sharing_ipd": "No"}}}